Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Human Immunodeficiency Virus | Research

HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021

Authors: Hang Hong, Chunlan Tang, Yuhui Liu, Haibo Jiang, Ting Fang, Guozhang Xu

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

As the HIV epidemic continues to grow, transmitted drug resistance(TDR) and determining relationship of HIV transmission are major barriers to reduce the risk of HIV transmissions.This study aimed to examine the molecular epidemiology and TDR and evaluated the transmission pattern among newly diagnosed people living with HIV/AIDS(PLWHA) in Ningbo city, which could contribute to the development of targeted precision interventions.

Methods

Consecutive cross-sectional surveys were conducted in Ningbo City between January 2018 and December 2021. The HIV-1 pol gene region was amplified and sequenced for drug resistance and genetic transmission network analysis. TDR was determined using the Stanford University HIV Drug Resistance Database. Genetic transmission network was visualized using Cytoscape with the genetic distance threshold of 0.013.

Results

A total of 1006 sequences were sequenced successfully, of which 61 (6.1%) showed evidence of TDR. The most common mutations were K103N (2.3%), E138A/G/Q (1.7%) and V179D/E (1.2%). 12 HIV-1 genotypes were identified, with CRF07_BC being the major genotype (43.3%, 332/767), followed by CRF01_AE (33.7%, 339/1006). 444 (44.1%) pol sequences formed 856 links within 120 transmission clusters in the network. An increasing trend in clustering rate between 2018 and 2021(χ2 = 9.546, P = 0.023) was observed. The odds of older age (≥ 60 years:OR = 2.038, 95%CI = 1.072 ~ 3.872, compared to < 25 years), HIV-1 genotypes (CRF07_BC: OR = 2.147, 95%CI = 1.582 ~ 2.914; CRF55_01B:OR = 2.217, 95%CI = 1.201 ~ 4.091, compared to CRF01_AE) were significantly related to clustering. Compared with CRF01_AE, CRF07_BC were prone to form larger clusters. The largest cluster with CRF07_BC was increased from 15 cases in 2018 to 83 cases in 2021.

Conclusions

This study revealed distribution of HIV-1 genotypes, and genetic transmission network were diverse and complex in Ningbo city. The prevalence of TDR was moderate, and NVP and EFV were high-level NNRTI resistance. Individuals aged ≥ 60 years old were more easily detected in the networks and CRF07_BC were prone to form rapid growth and larger clusters. These date suggested that surveillance and comprehensive intervention should be designed for key rapid growth clusters to reduce the potential risk factors of HIV-1 transmission.
Literature
4.
go back to reference Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, Jarrin I, et al. Limiting cumulative HIV Viremia Copy-Years by Early Treatment reduces risk of AIDS and Death. J Acquir Immune Defic Syndr. 2016;73:100–8.CrossRefPubMedPubMedCentral Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, Jarrin I, et al. Limiting cumulative HIV Viremia Copy-Years by Early Treatment reduces risk of AIDS and Death. J Acquir Immune Defic Syndr. 2016;73:100–8.CrossRefPubMedPubMedCentral
5.
go back to reference TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A trial of early antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015;373:808–22.CrossRef TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A trial of early antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015;373:808–22.CrossRef
6.
go back to reference INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.CrossRef INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.CrossRef
7.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.CrossRefPubMedPubMedCentral Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.CrossRefPubMedPubMedCentral
8.
go back to reference Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–38.CrossRefPubMedPubMedCentral Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–38.CrossRefPubMedPubMedCentral
9.
go back to reference Kroon EDMB, Phanuphak N, Shattock AJ, Fletcher JLK, Pinyakorn S, Chomchey N, et al. Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok. J Int AIDS Soc. 2017;20:21708.CrossRefPubMedPubMedCentral Kroon EDMB, Phanuphak N, Shattock AJ, Fletcher JLK, Pinyakorn S, Chomchey N, et al. Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok. J Int AIDS Soc. 2017;20:21708.CrossRefPubMedPubMedCentral
10.
go back to reference Kiekens A, Dierckx de Casterlé B, Pellizzer G, Mosha IH, Mosha F, Rinke de Wit TF, et al. Exploring the mechanisms behind HIV drug resistance in sub-saharan Africa: conceptual mapping of a complex adaptive system based on multi-disciplinary expert insights. BMC Public Health. 2022;22:1–15.CrossRef Kiekens A, Dierckx de Casterlé B, Pellizzer G, Mosha IH, Mosha F, Rinke de Wit TF, et al. Exploring the mechanisms behind HIV drug resistance in sub-saharan Africa: conceptual mapping of a complex adaptive system based on multi-disciplinary expert insights. BMC Public Health. 2022;22:1–15.CrossRef
11.
go back to reference Pang X, Tang K, He Q, Huang J, Fang N, Zhou X, et al. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China. BMC Infect Dis. 2021;21:160.CrossRefPubMedPubMedCentral Pang X, Tang K, He Q, Huang J, Fang N, Zhou X, et al. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China. BMC Infect Dis. 2021;21:160.CrossRefPubMedPubMedCentral
12.
go back to reference Leitner T, Romero-Severson E. Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants. Nat Microbiol. 2018;3:983–8.CrossRefPubMedPubMedCentral Leitner T, Romero-Severson E. Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants. Nat Microbiol. 2018;3:983–8.CrossRefPubMedPubMedCentral
13.
go back to reference Lundgren E, Romero-Severson E, Albert J, Leitner T. Combining biomarker and virus phylogenetic models improves HIV-1 epidemiological source identification. PLoS Comput Biol. 2022;18:e1009741.CrossRefPubMedPubMedCentral Lundgren E, Romero-Severson E, Albert J, Leitner T. Combining biomarker and virus phylogenetic models improves HIV-1 epidemiological source identification. PLoS Comput Biol. 2022;18:e1009741.CrossRefPubMedPubMedCentral
14.
go back to reference Liu M, Han X, Zhao B, An M, He W, Wang Z, et al. Dynamics of HIV-1 Molecular Networks reveal Effective Control of large transmission clusters in an area affected by an epidemic of multiple HIV subtypes. Front Microbiol. 2020;11:604993.CrossRefPubMedPubMedCentral Liu M, Han X, Zhao B, An M, He W, Wang Z, et al. Dynamics of HIV-1 Molecular Networks reveal Effective Control of large transmission clusters in an area affected by an epidemic of multiple HIV subtypes. Front Microbiol. 2020;11:604993.CrossRefPubMedPubMedCentral
15.
go back to reference Zhao B, Qiu Y, Song W, Kang M, Dong X, Li X, et al. Undiagnosed HIV infections may drive HIV Transmission in the era of treat all: a deep-sampling Molecular Network Study in Northeast China during 2016 to 2019. Viruses. 2022;14:1895.CrossRefPubMedPubMedCentral Zhao B, Qiu Y, Song W, Kang M, Dong X, Li X, et al. Undiagnosed HIV infections may drive HIV Transmission in the era of treat all: a deep-sampling Molecular Network Study in Northeast China during 2016 to 2019. Viruses. 2022;14:1895.CrossRefPubMedPubMedCentral
16.
go back to reference Matías-Florentino M, Chaillon A, Ávila-Ríos S, Mehta SR, Paz-Juárez HE, Becerril-Rodríguez MA, et al. Pretreatment HIV drug resistance spread within transmission clusters in Mexico City. J Antimicrob Chemother. 2020;75:656–67.CrossRefPubMed Matías-Florentino M, Chaillon A, Ávila-Ríos S, Mehta SR, Paz-Juárez HE, Becerril-Rodríguez MA, et al. Pretreatment HIV drug resistance spread within transmission clusters in Mexico City. J Antimicrob Chemother. 2020;75:656–67.CrossRefPubMed
17.
go back to reference Han X, Zhao B, An M, Zhong P, Shang H. Molecular network-based intervention brings us closer to ending the HIV pandemic. Front Med. 2020;14:136–48.CrossRefPubMed Han X, Zhao B, An M, Zhong P, Shang H. Molecular network-based intervention brings us closer to ending the HIV pandemic. Front Med. 2020;14:136–48.CrossRefPubMed
18.
go back to reference Dávila-Conn V, García-Morales C, Matías-Florentino M, López-Ortiz E, Paz-Juárez HE, Beristain-Barreda Á, et al. Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020. J Int AIDS Soc. 2021;24:e25836.CrossRefPubMedPubMedCentral Dávila-Conn V, García-Morales C, Matías-Florentino M, López-Ortiz E, Paz-Juárez HE, Beristain-Barreda Á, et al. Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020. J Int AIDS Soc. 2021;24:e25836.CrossRefPubMedPubMedCentral
19.
go back to reference Pasquale DK, Doherty IA, Sampson LA, Hué S, Leone PA, Sebastian J, et al. Leveraging phylogenetics to understand HIV Transmission and Partner Notification Networks. J Acquir Immune Defic Syndr. 2018;78:367–75.CrossRefPubMedPubMedCentral Pasquale DK, Doherty IA, Sampson LA, Hué S, Leone PA, Sebastian J, et al. Leveraging phylogenetics to understand HIV Transmission and Partner Notification Networks. J Acquir Immune Defic Syndr. 2018;78:367–75.CrossRefPubMedPubMedCentral
20.
go back to reference Kang R, Li J, Chen H, Tang Z, Pan SW, Luo L, et al. Using longitudinal genetic-network study to understand HIV treatment-as-prevention. AIDS. 2021;35:947–55.CrossRefPubMed Kang R, Li J, Chen H, Tang Z, Pan SW, Luo L, et al. Using longitudinal genetic-network study to understand HIV treatment-as-prevention. AIDS. 2021;35:947–55.CrossRefPubMed
21.
go back to reference Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321:844–5.CrossRefPubMed Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321:844–5.CrossRefPubMed
22.
go back to reference Hong H, Zhang DD, Jiang HB, Shi HB, Tan SW, Gu WZ, et al. [HIV infection and related factors of traceability efficiency among sex partners of HIV positive men who have sex with men]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42:2100–5.PubMed Hong H, Zhang DD, Jiang HB, Shi HB, Tan SW, Gu WZ, et al. [HIV infection and related factors of traceability efficiency among sex partners of HIV positive men who have sex with men]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42:2100–5.PubMed
23.
go back to reference Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35:1547–9.CrossRefPubMedPubMedCentral Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35:1547–9.CrossRefPubMedPubMedCentral
24.
go back to reference Hassan AS, Pybus OG, Sanders EJ, Albert J, Esbjörnsson J. Defining HIV-1 transmission clusters based on sequence data. AIDS. 2017;31:1211–22.CrossRefPubMed Hassan AS, Pybus OG, Sanders EJ, Albert J, Esbjörnsson J. Defining HIV-1 transmission clusters based on sequence data. AIDS. 2017;31:1211–22.CrossRefPubMed
25.
go back to reference Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining Challenges. Curr HIV/AIDS Rep. 2020;17:26–34.CrossRefPubMedPubMedCentral Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining Challenges. Curr HIV/AIDS Rep. 2020;17:26–34.CrossRefPubMedPubMedCentral
26.
go back to reference Zuo L, Liu K, Liu H, Hu Y, Zhang Z, Qin J, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001–2017). eClinicalMedicine. 2020;18:100238.CrossRefPubMedPubMedCentral Zuo L, Liu K, Liu H, Hu Y, Zhang Z, Qin J, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001–2017). eClinicalMedicine. 2020;18:100238.CrossRefPubMedPubMedCentral
27.
go back to reference Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE. 2009;4:e4724.CrossRefPubMedPubMedCentral Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE. 2009;4:e4724.CrossRefPubMedPubMedCentral
28.
go back to reference Zhou C, Liang S, Li Y, Zhang Y, Li L, Ye L, et al. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China. BMC Infect Dis. 2022;22:602.CrossRefPubMedPubMedCentral Zhou C, Liang S, Li Y, Zhang Y, Li L, Ye L, et al. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China. BMC Infect Dis. 2022;22:602.CrossRefPubMedPubMedCentral
29.
go back to reference Lan Y, Li L, He X, Hu F, Deng X, Cai W, et al. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study. Virol J. 2021;18:181.CrossRefPubMedPubMedCentral Lan Y, Li L, He X, Hu F, Deng X, Cai W, et al. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study. Virol J. 2021;18:181.CrossRefPubMedPubMedCentral
30.
go back to reference Yin Y, Zhou Y, Lu J, Liu X, Shi L, Fu G, et al. Molecular Epidemiology of HIV-1 in Jiangsu Province, Southeast China: genotypes and HIV-1 transmission networks among newly diagnosed Men having sex with men in 2017. AIDS Res Hum Retroviruses. 2021;37:62–9.CrossRefPubMed Yin Y, Zhou Y, Lu J, Liu X, Shi L, Fu G, et al. Molecular Epidemiology of HIV-1 in Jiangsu Province, Southeast China: genotypes and HIV-1 transmission networks among newly diagnosed Men having sex with men in 2017. AIDS Res Hum Retroviruses. 2021;37:62–9.CrossRefPubMed
31.
go back to reference Zhou F, Kominski GF, Qian H-Z, Wang J, Duan S, Guo Z, et al. Expenditures for the care of HIV-infected patients in rural areas in China’s antiretroviral therapy programs. BMC Med. 2011;9:6.CrossRefPubMedPubMedCentral Zhou F, Kominski GF, Qian H-Z, Wang J, Duan S, Guo Z, et al. Expenditures for the care of HIV-infected patients in rural areas in China’s antiretroviral therapy programs. BMC Med. 2011;9:6.CrossRefPubMedPubMedCentral
32.
go back to reference Cao Z, Li J, Chen H, Song C, Shen Z, Zhou X, et al. Effects of HIV-1 genotype on baseline CD4 + cell count and mortality before and after antiretroviral therapy. Sci Rep. 2020;10:15875.CrossRefPubMedPubMedCentral Cao Z, Li J, Chen H, Song C, Shen Z, Zhou X, et al. Effects of HIV-1 genotype on baseline CD4 + cell count and mortality before and after antiretroviral therapy. Sci Rep. 2020;10:15875.CrossRefPubMedPubMedCentral
33.
go back to reference Fan Q, Zhang J, Luo M, Feng Y, Ge R, Yan Y, et al. Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed Eastern China, 2017–2020. Emerg Microbes Infect. 2022;11:2326–39.CrossRefPubMedPubMedCentral Fan Q, Zhang J, Luo M, Feng Y, Ge R, Yan Y, et al. Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed Eastern China, 2017–2020. Emerg Microbes Infect. 2022;11:2326–39.CrossRefPubMedPubMedCentral
34.
go back to reference Li K, Liu M, Chen H, Li J, Liang Y, Feng Y, et al. Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China. Emerg Microbes Infect. 2021;10:497–506.CrossRefPubMedPubMedCentral Li K, Liu M, Chen H, Li J, Liang Y, Feng Y, et al. Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China. Emerg Microbes Infect. 2021;10:497–506.CrossRefPubMedPubMedCentral
35.
go back to reference Gan M, Zheng S, Hao J, Ruan Y, Liao L, Shao Y, et al. The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China. Emerg Microbes Infect. 2021;10:256–65.CrossRefPubMedPubMedCentral Gan M, Zheng S, Hao J, Ruan Y, Liao L, Shao Y, et al. The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China. Emerg Microbes Infect. 2021;10:256–65.CrossRefPubMedPubMedCentral
36.
go back to reference Wei L, Lu X, Li H, Zheng C, Li G, Yang Z, et al. Impact of HIV-1 CRF55_01B infection on CD4 counts and viral load in men who have sex with men naive to antiretroviral treatment. The Lancet. 2018;392:43.CrossRef Wei L, Lu X, Li H, Zheng C, Li G, Yang Z, et al. Impact of HIV-1 CRF55_01B infection on CD4 counts and viral load in men who have sex with men naive to antiretroviral treatment. The Lancet. 2018;392:43.CrossRef
37.
go back to reference Ding X, Chaillon A, Pan X, Zhang J, Zhong P, He L, et al. Characterizing genetic transmission networks among newly diagnosed HIV-1 infected individuals in eastern China: 2012–2016. PLoS ONE. 2022;17:e0269973.CrossRefPubMedPubMedCentral Ding X, Chaillon A, Pan X, Zhang J, Zhong P, He L, et al. Characterizing genetic transmission networks among newly diagnosed HIV-1 infected individuals in eastern China: 2012–2016. PLoS ONE. 2022;17:e0269973.CrossRefPubMedPubMedCentral
38.
go back to reference Zhang F, Yang Y, Liang N, Liang H, Chen Y, Lin Z, et al. Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China. Emerg Microbes Infect. 2023;12:2147023.CrossRefPubMed Zhang F, Yang Y, Liang N, Liang H, Chen Y, Lin Z, et al. Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China. Emerg Microbes Infect. 2023;12:2147023.CrossRefPubMed
39.
go back to reference Wertheim JO, Panneer N, France AM, Saduvala N, Oster AM. Incident infection in high-priority HIV molecular transmission clusters in the United States. AIDS. 2020;34:1187–93.CrossRefPubMed Wertheim JO, Panneer N, France AM, Saduvala N, Oster AM. Incident infection in high-priority HIV molecular transmission clusters in the United States. AIDS. 2020;34:1187–93.CrossRefPubMed
40.
go back to reference Beckwith CG, Min S, Manne A, Novitsky V, Howison M, Liu T, et al. HIV Drug Resistance and Transmission Networks among a justice-involved Population at the time of Community Reentry in Washington, D.C. AIDS Res Hum Retroviruses. 2021;37:903–12.CrossRefPubMedPubMedCentral Beckwith CG, Min S, Manne A, Novitsky V, Howison M, Liu T, et al. HIV Drug Resistance and Transmission Networks among a justice-involved Population at the time of Community Reentry in Washington, D.C. AIDS Res Hum Retroviruses. 2021;37:903–12.CrossRefPubMedPubMedCentral
Metadata
Title
HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021
Authors
Hang Hong
Chunlan Tang
Yuhui Liu
Haibo Jiang
Ting Fang
Guozhang Xu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02193-x

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.